Okamoto T - Search Results

1

[Diagnosis and management of asymptomatic MEN 2 gene carriers].

Okamoto T. Okamoto T. Nihon Rinsho. 2004 May;62(5):914-9. Nihon Rinsho. 2004. PMID: 15148818 Review. Japanese.

2

[The front line management of health risks from Fukushima nuclear power plant disaster].

Okamoto T. Okamoto T. Nihon Geka Gakkai Zasshi. 2012 May;113(3):308. Nihon Geka Gakkai Zasshi. 2012. PMID: 22708390 Japanese. No abstract available.

3

Diagnosis and management of adrenal incidentaloma: use of clinical judgment and evidence in dialog with the patient.

Yoshida Y, Horiuchi K, Otsuki M, Okamoto T. Yoshida Y, et al. Among authors: okamoto t. Surg Today. 2023 Dec 13. doi: 10.1007/s00595-023-02781-y. Online ahead of print. Surg Today. 2023. PMID: 38091063 Review.

4

Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.

Omi Y, Haniu K, Kamio H, Fujimoto M, Yoshida Y, Horiuchi K, Okamoto T. Omi Y, et al. Among authors: okamoto t. World J Surg Oncol. 2022 Dec 12;20(1):394. doi: 10.1186/s12957-022-02869-8. World J Surg Oncol. 2022. PMID: 36510206 Free PMC article.

5

Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma.

Horiuchi K, Fujimoto M, Hidenori K, Yoshida Y, Noguchi E, Omi Y, Okamoto T. Horiuchi K, et al. Among authors: okamoto t. World J Surg. 2023 Oct;47(10):2464-2473. doi: 10.1007/s00268-023-07073-7. Epub 2023 Jun 2. World J Surg. 2023. PMID: 37266697 Free PMC article.

6

Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?

Omi Y, Yanagida J, Yoshida Y, Horiuchi K, Okamoto T. Omi Y, et al. Among authors: okamoto t. Endocr J. 2024 Apr 30;71(4):357-362. doi: 10.1507/endocrj.EJ23-0413. Epub 2024 Jan 19. Endocr J. 2024. PMID: 38246643 Free article.

7

Predicting tumor volume in primary hyperparathyroidism from preoperative clinical data.

Nakai T, Horiuchi K, Okamoto T. Nakai T, et al. Among authors: okamoto t. J Clin Endocrinol Metab. 2024 Mar 25:dgae185. doi: 10.1210/clinem/dgae185. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38525667

8

Conditional Survival Rate Estimates for Anaplastic Thyroid Cancer Beyond the First Year: An Analysis of SEER Data (2004-2019).

Dong W, Okamoto T, Ji X, Xiang J, Zhang D, Zhang P, Zhang H. Dong W, et al. Among authors: okamoto t. Thyroid. 2023 Apr;33(4):523-526. doi: 10.1089/thy.2022.0339. Epub 2023 Feb 24. Thyroid. 2023. PMID: 36329668 No abstract available.

9

Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer.

Qu H, Zhang Z, Zhang D, Okamoto T, Zhang P, Zhang H, Dong W. Qu H, et al. Among authors: okamoto t. Thyroid. 2023 Oct;33(10):1264-1267. doi: 10.1089/thy.2022.0700. Epub 2023 Apr 28. Thyroid. 2023. PMID: 36974364 No abstract available.

10

Postoperative relative decrease in skeletal muscle mass as a predictor of quality of life in patients with gastric cancer.

Ueda Y, Seshimo A, Okamoto T. Ueda Y, et al. Among authors: okamoto t. Mol Clin Oncol. 2023 Jun 21;19(2):59. doi: 10.3892/mco.2023.2655. eCollection 2023 Aug. Mol Clin Oncol. 2023. PMID: 37424626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,153 results

Search Page

Filters